These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Health-care patents and interests of patients. Luthra R Bull World Health Organ; 2006 Nov; 84(11):919. PubMed ID: 17143470 [No Abstract] [Full Text] [Related]
30. Intellectual property rights in genes and gene fragments: a registration solution for expressed sequence tags. Holman MA; Munzer SR Iowa Law Rev; 2000 Mar; 85(3):735-848. PubMed ID: 16523593 [No Abstract] [Full Text] [Related]
31. The paths around stem cell intellectual property. Taymor KS; Scott CT; Greely HT Nat Biotechnol; 2006 Apr; 24(4):411-3. PubMed ID: 16601720 [TBL] [Abstract][Full Text] [Related]
32. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation. Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959 [No Abstract] [Full Text] [Related]
35. Genetic disease since 1945. Lindee MS Nat Rev Genet; 2000 Dec; 1(3):236-41. PubMed ID: 11252754 [TBL] [Abstract][Full Text] [Related]
36. Statement on the scope of gene patents, research exemption, and licensing of patented gene sequences for diagnostics. Human Genome Organisation (HUGO), Ethics Committee J Int Bioethique; 2003; 14(3-4):201-5. PubMed ID: 15281208 [No Abstract] [Full Text] [Related]
37. Patents, patients, and public policy: an incomplete intersection at 35 U.S.C. Section 287(c). Ho CM Univ Calif Davis Law Rev; 2000; 33(3):601-75. PubMed ID: 16389678 [No Abstract] [Full Text] [Related]
38. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]